Related Experiment Video
Updated: Jul 10, 2026

Mapping the Structure-Function Relationships of Disordered Oncogenic Transcription Factors Using Transcriptomic Analysis
Published on: June 27, 2020
A potential dichotomous role of ATF3, an adaptive-response gene, in cancer development
1The Ohio State Biochemistry Program, The Ohio State University, Columbus, OH, USA.
Abstract:
Activating transcription factor 3 (ATF3) is a member of the ATF/cyclic AMP response element-binding family of transcription factors. We present evidence that ATF3 has a dichotomous role in cancer development. By both gain- and loss-of-function approaches, we found that ATF3 enhances apoptosis in the untransformed MCF10A mammary epithelial cells, but protects the aggressive MCF10CA1a cells and enhances its cell motility. Array analyses indicated that ATF3 upregulates the expression of several genes in the tumor necrosis factor pathway in the MCF10A cells but upregulates the expression of several genes implicated in tumor metastasis, including TWIST1, fibronectin (FN)-1, plasminogen activator inhibitor-1, urokinase-type plasminogen activator, caveolin-1 and Slug, in the MCF10CA1a cells. We present evidence that ATF3 binds to the endogenous promoters and regulates the transcription of the TWIST1, FN-1, Snail and Slug genes. Furthermore, conditioned medium experiments indicated that ATF3 has a paracrine/autocrine effect, consistent with its upregulation of genes encoding secreted factors. Finally, ATF3 gene copy number is >2 in approximately 80% of the breast tumors examined (N=48) and its protein level is elevated in approximately 50% of the tumors. These results provided a correlative argument that it is advantageous for the malignant cancer cells to express ATF3, consistent with its oncogenic roles suggested by the MCF10CA1a cell data.
Insights
Activating transcription factor 3 (ATF3) plays a dual role in cancer. While it promotes apoptosis in normal cells, ATF3 enhances aggressive cancer cell motility and metastasis, suggesting an oncogenic function in tumors.
Area of Science:
- Molecular Biology
- Cancer Research
- Cell Biology
Background:
- Activating transcription factor 3 (ATF3) is a transcription factor belonging to the ATF/cyclic AMP response element-binding family.
- The role of ATF3 in cancer development is not fully understood, with potential for diverse functions.
Purpose of the Study:
- To investigate the dichotomous role of ATF3 in cancer development.
- To determine the specific molecular mechanisms by which ATF3 influences cancer cell behavior and gene expression.
Main Methods:
- Gain- and loss-of-function experiments in mammary epithelial cells (MCF10A and MCF10CA1a).
- Gene expression array analyses.
- Chromatin immunoprecipitation (ChIP) assays to assess promoter binding.
- Conditioned medium experiments to evaluate paracrine/autocrine effects.
- Analysis of ATF3 gene copy number and protein levels in breast tumors.
Main Results:
- ATF3 enhances apoptosis in untransformed MCF10A cells.
- ATF3 protects aggressive MCF10CA1a cells and promotes their motility.
- ATF3 upregulates tumor necrosis factor pathway genes in MCF10A cells.
- ATF3 upregulates metastasis-implicated genes (TWIST1, FN-1, Slug, etc.) in MCF10CA1a cells.
- ATF3 directly regulates the transcription of TWIST1, FN-1, Snail, and Slug genes.
- ATF3 exhibits paracrine/autocrine effects.
- Elevated ATF3 gene copy number (>2 in ~80%) and protein levels (~50%) in breast tumors.
Conclusions:
- ATF3 exhibits a dichotomous role in cancer, promoting apoptosis in normal cells but enhancing aggressive cancer cell phenotypes.
- ATF3's oncogenic roles in metastasis and cell motility are supported by its regulation of key genes and its prevalence in breast tumors.
- The findings suggest that ATF3 expression is advantageous for malignant cancer cells.
Related Concept Videos
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
Cancer-Critical Genes II: Tumor Suppressor Genes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Cancer-Critical Genes II: Tumor Suppressor Genes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase
Cancer-Critical Genes I: Proto-oncogenes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Abnormal Proliferation